Daiwa Securities Group Inc. - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 151 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2
-50.0%
2580.0%0.00%
Q2 2023$4
-33.3%
2580.0%0.00%
Q1 2023$6
+20.0%
2580.0%0.00%
Q4 2022$5
-99.9%
258
+24.0%
0.00%
Q3 2022$5,0000.0%2080.0%0.00%
Q2 2022$5,0000.0%2080.0%0.00%
Q1 2022$5,000
-16.7%
2080.0%0.00%
Q4 2021$6,000
+20.0%
2080.0%0.00%
Q3 2021$5,000
+150.0%
208
+82.5%
0.00%
Q2 2021$2,000
-33.3%
1140.0%0.00%
Q1 2021$3,0000.0%114
+18.8%
0.00%
Q4 2020$3,000960.00%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,084,300$15,820,0003.32%
ARMISTICE CAPITAL, LLC 5,748,000$83,863,0001.50%
RA Capital Management 5,614,428$81,915,0001.32%
Krensavage Asset Management, LLC 140,000$2,043,0000.69%
CM Management, LLC 60,000$875,0000.63%
Altium Capital Management LP 170,484$2,487,0000.58%
HighVista Strategies LLC 53,498$781,0000.55%
Sio Capital Management, LLC 150,000$2,189,0000.54%
MANGROVE PARTNERS IM, LLC 295,037$4,305,0000.44%
Rock Springs Capital Management LP 1,494,164$21,800,0000.43%
View complete list of TRAVERE THERAPEUTICS INC shareholders